AI-generated summary
The authors report testing low-level light therapy on mice with dextran sodium sulfate-induced colitis across four blinded controlled studies, using LED light at 440, 660, and 850 nm. They found statistically significant improvement in disease severity in treated groups compared with controls, with a dose-response curve seen at 850 nm. These findings come from an animal model, so applicability to humans is not established.
- Who or what was studied
- Mice with dextran sodium sulfate-induced acute colitis
- Wavelengths
- 440, 660, 850 nm
- Limits stated in the abstract
- The study was conducted in an acute mouse model of colitis, which the abstract does not show translates to human disease.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 850 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Dose, Light-emitting diode, Oral mucositis, Sham. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.